Thiazolinylthiazole

• 分子结构分类: 有机化合物 - 有机硫化合物 - 亚氨硫酯类
• 英文名称: Thiazolinylthiazole
• 英文别名: 2-(4,5-dihydro-1,3-thiazol-2-yl)-1,3-thiazole
• 化学式: C₆H₆N₂S₂
• 分子量: 170.3
• InChiKey: RSPLFXGIEYTXSZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  78.8
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• [EN] IMIDAZOLINONE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS D'IMIDAZOLINONE EN TANT QU'ANTAGONISTES DE RÉCEPTEURS CGRP
  申请人：MERCK SHARP & DOHME

  公开号：WO2010077752A1

  公开（公告）日：2010-07-08

  The present invention is directed to imidazolinone derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

  本发明涉及嘧啶啉酮衍生物，其为CGRP受体拮抗剂，可用于治疗或预防涉及CGRP的疾病，如偏头痛。该发明还涉及包含这些化合物的药物组合物，以及在预防或治疗涉及CGRP的这类疾病中使用这些化合物和组合物。
• Method for preparing largazole analogs and uses thereof
  申请人：Williams Robert M.

  公开号：US20100029731A1

  公开（公告）日：2010-02-04

  Analogs of largazole are described herein. Methods of treating cancer and blood disorders using largazole and largazole analogs and pharmaceutical compositions comprising the same are additionally described herein. Methods for preparing largazole analogs are likewise described.

  本文描述了类似largazole的类似物。此外，还描述了使用largazole和largazole类似物治疗癌症和血液疾病的方法，以及包含它们的药物组合物。同样描述了制备largazole类似物的方法。
• [EN] HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] DÉRIVÉS D'ACIDE HYDROXAMIQUE ET LEUR UTILISATION DANS LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：ACHAOGEN INC

  公开号：WO2012154204A1

  公开（公告）日：2012-11-15

  Antibacterial compounds of Formula I are provided: as well as stereoisomers and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; use of such compounds in the treatment of bacterial infections and processes for the preparation of such compounds.

  提供了化学式I的抗菌化合物：以及其立体异构体和药学上可接受的盐；包含这些化合物的药物组合物；通过给予这些化合物治疗细菌感染的方法；利用这些化合物治疗细菌感染以及制备这些化合物的方法。
• Pteridinone derivatives for treating ocular hypertension
  申请人：Zhu Song

  公开号：US20050250779A1

  公开（公告）日：2005-11-10

  This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which lead to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.

  这项发明涉及用于治疗青光眼以及其他导致患者眼内压增高的状况的强效钾通道阻断化合物，其化学式为I或其制剂。该发明还涉及使用这些化合物来为哺乳动物，特别是人类的眼提供神经保护作用。
• HDAC Inhibitors as Anti-Cancer Agents
  申请人：The University of Toledo

  公开号：US20150329560A1

  公开（公告）日：2015-11-19

  Largazole analogues, methods of making the same, and methods of using the same, are described.

  Largazole类似物，其制备方法和使用方法被描述。